Ação PRVA atinge alta de 52 semanas após aumento de guidance; Batida do segundo trimestre (NASDAQ:PRVA)


Jornal enrolado com a manchete Resultados Trimestrais

Zerbor/iStock via Getty Images

Privia Health (NASDAQ:PRVA), a provider of value-based care, reported better than expected financials for Q2 2022 and raised its full-year outlook sending its shares a 52-week in the morning hours Thursday.

Privia’s (PRVA) revenue for the quarter jumped ~49% YoY to $335.5M as practice collections improved ~67% YoY to $615.5M while value-based care attributed lives gained ~16% YoY ~856K.

As care margin improved ~36% YoY to $76.2M, the net loss for the quarter narrowed to $10.5M from $172.5M in the prior-year quarter when the company recorded $202.6M of non-cash or non-recurring expenses.

Revenue for the first half of the year ~48% YoY to $649.3M, driven by a ~66% YoY growth in practice collections that generated $~$1.2B.

Enquanto isso, o caixa e equivalentes caíram ~ 9% no final do ano de 2021 para US$ 292,2 milhões com o pagamento total da dívida pendente durante o trimestre.

Para refletir o forte desempenho no primeiro semestre e o impulso contínuo dos negócios, a Privia ( PRVA ) elevou sua perspectiva para o ano inteiro, definindo a estimativa de receita para 2022 no limite superior da visão anterior.

A empresa projetou cerca de US$ 1,23 bilhão a US$ 1,30 de receita para 2022, inicialmente de acordo com o consenso atual.

Source: https://seekingalpha.com/news/3871711-prva-stock-hits-52-week-high-after-guidance-raise-q2-beat